• home
  • FINAL PROGRAMME
  • TIMETABLE
  • DIGITAL SERVICES
  • FACTS&FIGURES
breaking news
  • ERA-EDTA Congress 2015: Posters are available online!
  • Monitoring CRP-levels might be useful
  • Vitamin D – to whom, what and when?
  • Continuous fight against kidney disease
  • Welcome to the new CKJ
  • Improve the outcome in a sustainable way
  • The nephrologists of tomorrow
  • The burden of AKI throughout the world
  • Uremic toxin retention on acute kidney injury
  • The DOPPS programme continues to grow
  • ERA-EDTA honours three members
  • Increasingly interdisciplinary times
  • A need for better educational programmes
  • Considerations for the revised guidelines
  • Changing trends of renal replacement therapy
  • A big welcome to London
feed rss
  • FACTS&FIGURES
  • SCIENTIFIC AND ORGANISING COMMITTEES
  • FINAL PROGRAMME
  • DISCLOSURE OF INTERESTS
  • IMPORTANT ADDRESSES
  • TIMETABLE
  • SATELLITE MEETINGS
  • DIGITAL SERVICES
  • TRAVEL GRANTS
  • REGISTRATIONS
  • HOTEL ACCOMMODATION
  • GENERAL INFORMATION
  • EXHIBITION
  • Industry Symposia
  • PRESS
  • PUBLISHERS&JOURNALS
  • ALTRUISTIC SUPPORT BY QUESTIONNAIRE (ASQ)
decorazione
Renal Association

Preliminary Scientific Programme "day by day" - may 28 - 31, 2015

today

today
  • May 28 - H 9.00-12.15

    ROOM N11
    CME 1

    EURECA-m

    EURECA-m WG
    Updates in cardiorenal cross-talks

    May 28 - H 9.00-12.15

    ROOM N10
    CME 2

    ckd

    CKD-MBD WG
    Adipokines and vascular disease

    May 28 - H 9.00-12.15

    CAPITAL SUITE 14/15/16
    CME 3

    Descartes

    DESCARTES WG
    Tolerance, minimization, and living donation in 2015

    May 28 - H 9.00-12.15

    CAPITAL SUITE 7/12
    CME 4

    IWG

    IWG WG
    Immune mediated renal diseases: news from the ERA-EDTA IWG

    May 28 - H 9.00-12.15

    CAPITAL SUITE 10/11
    CME 5

    Eudial

    EUDIAL WG
    The rationale for high volume haemodia_
    filtration

  • May 28 - H 9.00-12.15

    CAPITAL SUITE 8/9
    CME 6

    Diabesity

    DIABESITY WG
    DIABESITY Diabetes, Obesity and Renal Disease

    May 28 - H 9.00-12.15

    CAPITAL SUITE 2/3/4
    CME 7

    EUtox

    EUTox WG
    Uremic toxicity: the compounds and how to clear them

    May 28 - H 9.00-12.15

    CAPITAL SUITE 17
    CME 8

    WGIKD

    WGIKD
    An update on Inherited Kidney Disorders

    May 28 - H 13.15-15.15

    ROOM N11
    CME 9

    EuroPD

    EuroPD 1
    Basic clinical CME

    May 28 - H 13.15-15.15

    ROOM N10
    CME 10

    Rheumatology for nephrologists

  • May 28 - H 13.15-15.15

    CAPITAL SUITE 14/15/16
    CME 11

    ERBP

    Guidelines for the daily care of your patients

    May 28 - H 13.15-15.15

    CAPITAL SUITE 10/11
    CME 13

    ERN

    EUROPEAN RENAL NUTRITION WG (ERN)
    Do renal diseases need a Nutrition Working Group?

    May 28 - H 13.15-15.15

    CAPITAL SUITE 8/9
    CME 14

    Perspectives on renal stone disease

    May 28 - H 13.15-15.15

    CAPITAL SUITE 2/3/4
    CME 15

    Exercise as Medicine in CKD  

    May 28 - H 13.15-16.15

    CAPITAL SUITE 7/12
    CME 12

    Cross-talk in Renal Epidemiology

  • May 28 - H 15.30-17.30

    CAPITAL SUITE 8/9
    CME 16

    EuroPD

    EuroPD 2
    Advanced level clinical CME

    May 28 - H 15.30-17.30

    ROOM N10
    CME 17

    Current questions in clinical practice regarding AKI

    May 28 - H 15.30-17.30

    CAPITAL SUITE 14/15/16
    CME 18

    The Lancet

    The Lancet and ERA-EDTA journals publishing workshop

    May 28 - H 15.30-17.30

    CAPITAL SUITE 8/9
    CME 19

    Genetics and kidney disease for the beginners

    May 28 - H 18.00-19.30

    ICC AUDITORIUM
    WELCOME CEREMONY

    Welcome Ceremony

  • May 28 - H 19.30-21.00

    Welcome RECEPTION in the Exhibition

    May 29 - H 8.00-9.30

    ICC AUDITORIUM
    SYMPOSIUM 1

    Mechanisms and effects of renal remodelling and ageing

    May 29 - H 8.00-9.30

    ROOM N11
    SYMPOSIUM 2

    Obesity and the kidney

    May 29 - H 8.00-9.30

    ROOM N10
    SYMPOSIUM 3

    Everyday questions from the glomerulo_
    nephritis clinic

     

    May 29 - H 8.00-9.30

    ROOM S11
    SYMPOSIUM 4

    Registry

    ERA-EDTA Registry

  • May 29 - H 8.00-9.30

    SYMPOSIUM 5

    AKI: general concepts, definition, validation, implementation

    May 29 - H 8.00-9.30

    CAPITAL SUITE 14/15/16
    MASTERCLASS 1

    Translation of physiology to the clinic

    May 29 - H 8.00-9.30

    CAPITAL SUITE 7/12
    Free Communication 1

    CKD inflammation and aging

    May 29 - H 8.00-9.30

    FREE COMMUNICATION 2

    Experimental AKI

    May 29 - H 10.45-11.30

    ICC AUDITORIUM
    PLENARY LECTURE 1

    Longevity, DNA repair and metabolism

  • May 29 - H 13.30-15.00

    Room N10
    Industry Symposium 1

    OTSUKA PHARMACEUTICAL EUROPE

    May 29 - H 13.30-15.00

    Room N11
    Industry Symposium 2

    FRESENIUS MEDICAL CARE

    May 29 - H 13.30-15.00

    Room S11
    Industry Symposium 3

    BAXTER HEALTHCARE

    May 29 - H 13.30-15.00

    Capital Suite 14-15-16
    Industry Symposium 4

    VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

    May 29 - H 13.30-15.00

    Capital Suite 7-12
    Industry Symposium 5

    KERYX BIOPHARMA_
    CEUTICALS

  • May 29 - H 13.30-15.00

    Capital Suite 8-9
    Industry Symposium 6

    ALEXION PHARMA INTERNATIONAL

    May 29 - H 13.30-15.00

    Capital Suite 2-3-4
    Industry Symposium 7

    RAPTOR PHARMACEUTICALS

    May 29 - H 11.45-13.15

    ICC AUDITORIUM
    SYMPOSIUM 6

    Late Breaking Clinical Trials

    May 29 - H 11.45-13.15

    ROOM N11
    SYMPOSIUM 7

    CKD-MBD: update 2015

     

    May 29 - H 11.45-13.15

    ROOM N10
    SYMPOSIUM 8

    New aspects of podocyte diseases, podocyte stress

     

  • May 29 - H 11.45-13.15

    ROOM S11
    SYMPOSIUM 9

    How to avoid / treat AKI: What do we know? What do we hope?

     

    May 29 - H 11.45-13.15

    CAPITAL SUITE 14/15/16
    FREE COMMUNICATION 3

    Tubules and mineral metabolism

    May 29 - H 11.45-13.15

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 4

    Anaemia - novel approaches

    May 29 - H 11.45-13.15

    FREE COMMUNICATION 5

    Endothelial pathophysiology

    May 29 - H 11.45-13.15

    CAPITAL SUITE 17
    SYMPOSIUM 10

    NDT Pearls and Polar Views

  • May 29 - H 15.15-16.45

    ICC AUDITORIUM
    SYMPOSIUM 11

    Age dependent problems in transplanta_
    tion

     

    May 29 - H 15.15-16.45

    ROOM N11
    SYMPOSIUM 12

    The Lancet/The Lancet Diabetes and Endocrinology - Research

    May 29 - H 15.15-16.45

    ROOM N10 15:15
    SYMPOSIUM 13

    Diabetes, blood pressure and kidney disease

    May 29 - H 15.15-16.45

    ROOM S11 15:15
    SYMPOSIUM 14

    ERA EDTA & ESH Joint Symposium

     

    May 29 - H 15.15-16.45

    CAPITAL SUITE 14/15/16
    FREE COMMUNICATION 6

    HD new technologies

  • May 29 - H 15.15-16.45

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 7

    Exercise and rehabilitation

    May 29 - H 15.15-16.45

    CAPITAL SUITE 10/11
    FREE COMMUNICATION 8

    Podocytes

    May 29 - H 15.15-16.45

    CAPITAL SUITE 8/9
    The Renal Association Session

    The Renal Association
    Renal Scien_
    tists New Investigator Award Session

    May 29 - H 17.00-18.30

    ICC AUDITORIUM
    SYMPOSIUM 15

    ASN Highlights

    May 29 - H 17.00-18.30

    ROOM N11
    SYMPOSIUM 16

    Aging kidney

     

  • May 29 - H 17.00-18.30

    ROOM N10
    SYMPOSIUM 17

    Dialysis in the elderly

    May 29 - H 17.00-18.30

    ROOM S11
    SYMPOSIUM 18

    Storage and traffic disorders

    May 29 - H 17.00-18.30

    CAPITAL SUITE 14/15/16
    SYMPOSIUM 19

    Prognosis and therapy of diabetic nephropathy: one size does not fit them all (SYSKID)

    May 29 - H 17.00-18.30

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 9

    Paediatric nephrology

    May 29 - H 17.00-18.30

    FREE COMMUNICATION 10

    Experimental hypertension

  • May 30 - H 08.00-09.30

    ICC AUDITORIUM
    SYMPOSIUM 20

    HLA and non-HLA Antibodies Avoid them or treat them?

    May 30 - H 08.00-09.30

    ROOM N11
    SYMPOSIUM 21

    ADPKD

    May 30 - H 08.00-09.30

    ROOM N10
    SYMPOSIUM 22

    B-cell targeted treatment in glomerular disease

    May 30 - H 08.00-09.30

    ROOM S11
    SYMPOSIUM 23

    Vascular calcification: what’s new?

    May 30 - H 08.00-09.30

    CAPITAL SUITE 14/15/16
    SYMPOSIUM 24

    International Practices and Improved Dialysis Outcomes: The DOPPS Program

  • May 30 - H 08.00-09.30

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 11

    Renal denervation

    May 30 - H 08.00-09.30

    CAPITAL SUITE 10/11
    FREE COMMUNICATION 12

    Clinical AKI - 1

    May 30 - H 08.00-09.30

    CAPITAL SUITE 17
    MASTERCLASS 2

    Basic science translated from and to PD

    May 30 - H 9.30-10.45

    ERA-EDTA GENERAL ASSEMBLY

    ERA-EDTA

    General Assembly

     

    May 30 - H 10.45-11.30

    ICC AUDITORIUM
    PLENARY LECTURE 2

    Salt - a health problem?

  • May 30 - H 13.30-15.00

    Room N11
    Industry Symposium 8

    BAXTER HEALTHCARE

    May 30 - H 13.30-15.00

    Room N10
    Industry Symposium 9

    VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

    May 30 - H 13.30-15.00

    Room S11
    Industry Symposium 10

    OTSUKA PHARMACEUTICAL EUROPE

    May 30 - H 13.30-15.00

    Capital Suite 14-15-16
    Industry Symposium 11

    PHARMACOSMOS

    May 30 - H 13.30-15.00

    Capital Suite 7-12
    Industry Symposium 12

    B.BRAUN

  • May 30 - H 13.30-15.00

    Capital Suite 10-11
    Industry Symposium 13

    TORAY

    May 30 - H 13.30-15.00

    Capital Suite 17
    Industry Symposium 14

    ABBVIE

    May 30 - H 13.30-15.00

    Capital Suite 8-9
    Industry Symposium 15

    ZS PHARMA

    May 30 - H 13.30-15.00

    Capital Suite 2-3-4
    Industry Symposium 16

    GENZYME

    May 30 - H 11.45-13.15

    ICC AUDITORIUM
    SYMPOSIUM 25

    Uremic toxicities

  • May 30 - H 11.45-13.15

    ROOM N11
    SYMPOSIUM 26

    The Lancet/The Lancet Diabetes and Endocrinology - Review

    May 30 - H 11.45-13.15

    ROOM N10
    SYMPOSIUM 27

    Biomarkers

    May 30 - H 11.45-13.15

    ROOM S11
    SYMPOSIUM 28

    ISN Session: addressing the global unmet needs for AKI

    May 30 - H 11.45-13.15

    CAPITAL SUITE 14/15/16
    SYMPOSIUM 29

    YNP

    Young Nephrologists’ Platform (YNP)

    May 30 - H 11.45-13.15

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 13

    Vascular access and peritoneal dialysis

  • May 30 - H 11.45-13.15

    CAPITAL SUITE 10/11
    FREE COMMUNICATION 14

    Experimental and clinical transplantation

    May 30 - H 11.45-13.15

    CAPITAL SUITE 8/9
    FREE COMMUNICATION 15

    Experimental and translational glomerulonephritis

    May 30 - H 15.15-16.45

    ICC AUDITORIUM
    SYMPOSIUM 30

    IgA nephropathy

    May 30 - H 15.15-16.45

    ROOM N11
    SYMPOSIUM 31

    Patient satisfaction

    May 30 - H 15.15-16.45

    ROOM N10
    SYMPOSIUM 32

    Haemolytic Uremic Syndrome - a complement disorder

  • May 30 - H 15.15-16.45

    ROOM S11
    SYMPOSIUM 33

    ERA-EDTA & CSN Joint Symposium

    May 30 - H 15.15-16.45

    SYMPOSIUM 34

    Lipoproteins in CKD revisited

    May 30 - H 15.15-16.45

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 16

    New players in CKD-MBD

    May 30 - H 15.15-16.45

    CAPITAL SUITE 10/11 15:15
    FREE COMMUNICATION 17

    Transplantation clinical

    May 30 - H 15.15-16.45

    CAPITAL SUITE 8/9
    THE RENAL ASSOCIATION SESSION 2

    The Renal Association
    Raine Session UK Best Abstracts and Raine Award Lecture

  • May 30 - H 17.00-18.30

    ICC AUDITORIUM
    SYMPOSIUM 35

    New insights into phosphate handling by kidney, bone and vasculature

    May 30 - H 17.00-18.30

    ROOM N11
    SYMPOSIUM 36

    Hypercoagulability in ESRD: Myth or reality?

    May 30 - H 17.00-18.30

    ROOM N10
    SYMPOSIUM 37

     
    ERA-EDTA & JSN Joint Symposium

    May 30 - H 17.00-18.30

    ROOM S11
    SYMPOSIUM 38

    Viruses: transplantation in the light of new treatment options

    May 30 - H 17.00-18.30

    CAPITAL SUITE 14/15/16
    FREE COMMUNICATION 18

    Uremic molecules

  • May 30 - H 17.00-18.30

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 19

    Vasculitis and lupus

    May 30 - H 17.00-18.30

    CAPITAL SUITE 10/11
    FREE COMMUNICATION 20

    Pregnancy and neonatology

    May 31 - H 08.00-09.30

    ICC AUDITORIUM
    SYMPOSIUM 39

    Novel therapeutic approaches in glomerular diseases

    May 31 - H 08.00-09.30

    ROOM N11
    SYMPOSIUM 40

    Acid-base regulation and the kidney

    May 31 - H 08.00-09.30

    ROOM N10
    SYMPOSIUM 41

    RRT and AKI

  • May 31 - H 08.00-09.30

    ROOM S11
    SYMPOSIUM 42

    Disease recurrence – are there new treatment strategies on the horizon?

    May 31 - H 08.00-09.30

    CAPITAL SUITE 14/15/16
    SYMPOSIUM 43

    ERA-EDTA & ESC Joint Symposium

    May 31 - H 08.00-09.30

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 21

    Dialysis cardiovascular pathophysiology

    May 31 - H 08.00-09.30

    CAPITAL SUITE 10/11
    FREE COMMUNICATION 22

    CKD progression and outcomes

    May 31 - H 9.45-10-30

    ICC AUDITORIUM
    PLENARY LECTURE 3

    Stem cells and pluripotency: mechanisms of reprogramming and gene targeting in ES cells and mice

  • May 31 - H 10.45-12.15

    ICC AUDITORIUM
    SYMPOSIUM 44

    From kidney development to kidney regeneration: deciphering developmental cues to engineer kidneys

    May 31 - H 10.45-12.15

    ROOM N11
    SYMPOSIUM 45

    Vitamin D deficiency in CKD patients

    May 31 - H 10.45-12.15

    ROOM N10
    SYMPOSIUM 46

    Inflammation in CKD and dialysis patients

    May 31 - H 10.45-12.15

    ROOM S11
    SYMPOSIUM 47

    Channels and transporters: new drug targets

    May 31 - H 10.45-12.15

    CAPITAL SUITE 14/15/16
    FREE COMMUNICATION 23

    History of nephrology

  • May 31 - H 10.45-12.15

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 24

    Sodium, potassium and blood pressure

    May 31 - H 10.45-12.15

    CAPITAL SUITE 10/11
    FREE COMMUNICATION 25

    Diabetic nephropathy - new therapies

    May 31 - H 12:15-13:15

    Capital Suite 2-3-4
    Industry Symposium 17

    BAXTER HEALTHCARE

    May 31 - H 13.15-14.45

    ICC AUDITORIUM
    SYMPOSIUM 48

    Renovascular hypertension – when and whom to offer revascularisation?

    May 31 - H 13.15-14.45

    ROOM N11
    SYMPOSIUM 49

    Growth in pediatric kidney disease

  • May 31 - H 13.15-14.45

    ROOM N10
    SYMPOSIUM 50

    New osmotic agents

    May 31 - H 13.15-14.45

    ROOM S11
    FREE COMMUNICATION 26

    Genetics of the tubule

    May 31 - H 13.15-14.45

    CAPITAL SUITE
    FREE COMMUNICATION 27

    Registries

    May 31 - H 13.15-14.45

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 28

    Clinical AKI - 2

    May 31 - H 14.45-16.15

    ICC AUDITORIUM
    SYMPOSIUM 51

    Proteinuria: therapies beyond renin-angiotensin inhibition

  • May 31 - H 14.45-16.15

    ROOM N11
    SYMPOSIUM 52

    Personalised care and dialysis

    May 31 - H 14.45-16.15

    ROOM N10
    SYMPOSIUM 53

    Hot ethical issues in modern nephrology

    May 31 - H 14.45-16.15

    ROOM S11
    SYMPOSIUM 54

    What is new and hot in paediatric nephrology: report of ESPN Working Groups activity

    May 31 - H 14.45-16.15

    CAPITAL SUITE
    FREE COMMUNICATION 29

    PKD

    May 31 - H 14.45-16.15

    CAPITAL SUITE 7/12
    FREE COMMUNICATION 30

    New insights in renal physiopathology

  • Facebook ERA-EDTA
  • Youtube ERA-EDTA
  • Twitter ERA-EDTA
  • Twitter ERA-EDTA
  • Twitter ERA-EDTA

era-edta 52st congress official site

designed by gaf